Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol.
about
Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics features.Anemia and neutrophil-to-lymphocyte ratio are prognostic in p16-positive oropharyngeal carcinoma treated with concurrent chemoradiation.Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.
P2860
Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Do selective radiation dose es ...... tumours? The ESCALOX protocol.
@en
Do selective radiation dose es ...... tumours? The ESCALOX protocol.
@nl
type
label
Do selective radiation dose es ...... tumours? The ESCALOX protocol.
@en
Do selective radiation dose es ...... tumours? The ESCALOX protocol.
@nl
prefLabel
Do selective radiation dose es ...... tumours? The ESCALOX protocol.
@en
Do selective radiation dose es ...... tumours? The ESCALOX protocol.
@nl
P2093
P2860
P1433
P1476
Do selective radiation dose es ...... tumours? The ESCALOX protocol
@en
P2093
Christian Schläger
Henning Bier
Markus Schwaiger
Severin Kampfer
Steffi U Pigorsch
Stephanie E Combs
Victoria Kehl
P2860
P2888
P356
10.1186/S13014-017-0776-1
P577
2017-03-01T00:00:00Z
P6179
1084251739